Amgen : AMGN

All Amgen Articles

701 Articles

Douglas A. McIntyre | Oct 12, 2009 at 7:18 AM EDT

Top Analyst Upgrades (AMD, AMGN, BDK, BMY, CTXS, KR, MA, PCG, SYMC, V, VMW)

These are the top early-bird analyst upgrades and positive research calls which we have seen from Wall Street early this…

Douglas A. McIntyre | Sep 29, 2009 at 9:13 AM EDT

Today’s Best Market Rumors (9/29/2009) (AMD)(GOOG)(AMGN)

Updated throughout the day. Update: Xerox (XRX) may find that IBM (IBM) or HP (HPQ) outbid it for ACS (ACS) …

Douglas A. McIntyre | Sep 21, 2009 at 9:14 AM EDT

Top Day Trader Alerts (DPTR, AMGN, PER, DELL, LEN, POT, MOS)

These are this Monday’s top day trader and active trader alert stocks in the pre-market. We have more details on…

Douglas A. McIntyre | Aug 24, 2009 at 9:54 AM EDT

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the…

Douglas A. McIntyre | Aug 14, 2009 at 7:51 AM EDT

Top 10 Analyst Upgrades and Downgrades (AMGN, AVY, COLM, DSGX, EJ, JASO, KG, SCSS, SPWRA, THC)

These are the ten top analyst upgrades,downgrades, and initiations we have seen early this Friday morning with roughly two hours…

Douglas A. McIntyre | Aug 11, 2009 at 7:58 AM EDT

Top 10 Analyst Upgrades/Downgrades (AMGN, CELL, ELON, SATS, KR, QLGC, MBI, PETM, S, YUM)

These are the top 10 pre-market analyst upgrades and downgrades in Wall Street research calls this Tuesday morning: Amgen (AMGN)…

Douglas A. McIntyre | Jul 28, 2009 at 8:57 AM EDT

Top Day Trader Alerts (SPSS, X, VICL, AMGN, ARIA, LCRD, DB, COH, CHKP)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume…

Douglas A. McIntyre | Jul 28, 2009 at 3:49 AM EDT

Media Digest 7/28/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Reuters: The recession has badly hurt investments in green technologies. Reuters: Obama called for deeper China ties with the US.…

Douglas A. McIntyre | Jul 23, 2009 at 9:12 AM EDT

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 8, 2009 at 9:47 AM EDT

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details…

Douglas A. McIntyre | Jul 8, 2009 at 8:10 AM EDT

Day Trader Alerts (AMGN, NVS, MSCS, DRYS, ARYX, XNPT, ARNA, BPZ)

These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours…

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | May 27, 2009 at 1:34 PM EDT

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data…

Douglas A. McIntyre | May 6, 2009 at 6:26 AM EDT

Top Analyst Upgrades (ALU, AMGN, HBC, IFX, SMTC, DIS, WBMD)

These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this…

1 … 40 41 42 43 44 … 47

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades (AMD, AMGN, BDK, BMY, CTXS, KR, MA, PCG, SYMC, V, VMW)

Today’s Best Market Rumors (9/29/2009) (AMD)(GOOG)(AMGN)

Top Day Trader Alerts (DPTR, AMGN, PER, DELL, LEN, POT, MOS)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Top 10 Analyst Upgrades and Downgrades (AMGN, AVY, COLM, DSGX, EJ, JASO, KG, SCSS, SPWRA, THC)

Top 10 Analyst Upgrades/Downgrades (AMGN, CELL, ELON, SATS, KR, QLGC, MBI, PETM, S, YUM)

Top Day Trader Alerts (SPSS, X, VICL, AMGN, ARIA, LCRD, DB, COH, CHKP)

Media Digest 7/28/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

Day Trader Alerts (AMGN, NVS, MSCS, DRYS, ARYX, XNPT, ARNA, BPZ)

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Top Analyst Upgrades (ALU, AMGN, HBC, IFX, SMTC, DIS, WBMD)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades (AMD, AMGN, BDK, BMY, CTXS, KR, MA, PCG, SYMC, V, VMW)

Today’s Best Market Rumors (9/29/2009) (AMD)(GOOG)(AMGN)

Top Day Trader Alerts (DPTR, AMGN, PER, DELL, LEN, POT, MOS)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Top 10 Analyst Upgrades and Downgrades (AMGN, AVY, COLM, DSGX, EJ, JASO, KG, SCSS, SPWRA, THC)

Top 10 Analyst Upgrades/Downgrades (AMGN, CELL, ELON, SATS, KR, QLGC, MBI, PETM, S, YUM)

Top Day Trader Alerts (SPSS, X, VICL, AMGN, ARIA, LCRD, DB, COH, CHKP)

Media Digest 7/28/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

Day Trader Alerts (AMGN, NVS, MSCS, DRYS, ARYX, XNPT, ARNA, BPZ)

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Top Analyst Upgrades (ALU, AMGN, HBC, IFX, SMTC, DIS, WBMD)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings